Definitive Healthcare Corp. (DH)
NASDAQ: DH · IEX Real-Time Price · USD
5.62
-0.03 (-0.53%)
At close: Jul 19, 2024, 4:00 PM
5.67
+0.05 (0.89%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for DH stock have an average target of 9.39, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 67.08% from the current stock price of 5.62.
Analyst Consensus: Hold
* Price targets were last updated on May 9, 2024.
Analyst Ratings
The average analyst rating for DH stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains $10 → $7 | Hold | Maintains | $10 → $7 | +24.56% | May 9, 2024 |
| Barclays | Barclays | Hold Maintains $11 → $7 | Hold | Maintains | $11 → $7 | +24.56% | May 9, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +42.35% | May 8, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9.5 | Strong Buy | Maintains | $11 → $9.5 | +69.04% | May 8, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 8, 2024 |
Financial Forecast
Revenue This Year
266.03M
from 251.42M
Increased by 5.81%
Revenue Next Year
280.99M
from 266.03M
Increased by 5.62%
EPS This Year
0.38
from -1.79
EPS Next Year
0.41
from 0.38
Increased by 7.12%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 273.0M | 292.0M | 317.2M |
| Avg | 266.0M | 281.0M | 301.1M |
| Low | 251.8M | 258.9M | 267.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.6% | 9.7% | 12.9% |
| Avg | 5.8% | 5.6% | 7.1% |
| Low | 0.1% | -2.7% | -4.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.40 | 0.44 | 0.47 |
| Avg | 0.38 | 0.41 | 0.44 |
| Low | 0.33 | 0.36 | 0.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 16.2% | 16.3% |
| Avg | - | 7.1% | 9.0% |
| Low | - | -4.4% | -1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.